Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
People vary widely in their sensitivity to cold and heat -- but this could signal a thyroid problem.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
Cancer mortality fell by 29% between 1991 and 2017, largely driven by a decline in lung cancer deaths.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
Lonafarnib and bulevirtide, when used with pegylated interferon, reduced hepatitis delta levels in two studies.
Oncologist wins Senate backing by a vote of 72 to 18.
Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.
Nine grants will enable researchers to study CBD and other components of marijuana.
Smoking cessation, a healthy diet, exercise and weight loss could dramatically reduce new liver cancer cases and liver disease deaths.
Experimental therapy led to weight loss and improved biomarkers of liver health.
Nonetheless, half of people with NAFLD were able to reach a 5% weight loss goal using a very low energy diet.
Well-tolerated insulin sensitizer may play a role in the treatment of fatty liver disease.
Sustained response to direct-acting antivirals prolonged survival by a year and a half.
HCV incidence in a Canadian study was lower than rates seen in some European countries.
People treated with Viread, Vemlidy or Baraclude are less likely to develop this malignancy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.